Azacitidine – Treatment for Myelodysplastic Syndromes and Leukemia (100mg/ml)

Origin

United States of America

Azacitidine – Treatment for Myelodysplastic Syndromes and Leukemia (100mg/ml)

Azacitidine is a chemotherapy drug used to treat certain types of blood and bone marrow cancers. It is a demethylating (or hypomethylating) agent that works by helping the bone marrow produce normal blood cells and by destroying abnormal cancer cells.

Product Specifications

Active Ingredient
Azacitidine
Indication
Certain types of Leukemia, Myelodysplastic Syndromes (MDS)
Strength
100mg/ml
Packaging
1 vial
Storage Temperature
Controlled room temperature

Why Choose Uno Healthcare?

Quality Assured

All products undergo rigorous quality checks and are sourced from certified manufacturers.

Global Shipping

Reliable logistics partners ensuring safe and timely delivery to your facility.

Expert Support

Dedicated team available to assist with product inquiries and order management.